Article Text

Download PDFPDF
047 Clinicopathological characteristics impacting on survival in sporadic CJD: insights from an international autopsy-confirmed series
  1. Neil Watson1,
  2. Peter Hermann2,
  3. Anna Ladogana3,
  4. Alison Green1,
  5. David Summers1,
  6. Maurizio Pocchiari3,
  7. Inga Zerr2,
  8. Jean-Philippe Brandel4,
  9. Suvankar Pal1,
  10. et al1
  1. 1National CJD Research and Surveillance Unit, Edinburgh
  2. 2National Reference Centre for TSE, Goettingen, Germany
  3. 3Registry of CJD, Istituto Superiore di Sanita, Rome, Italy
  4. 4Cellule Nationale de Reference des MCJ, Paris, France
  5. 5IRRCS Istituo delle Scienze Neurologiche di Bologna, Bologna, Italy
  6. 6Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy
  7. 7Neurology/Neuropathology Unit, IRCCS, Milan, Italy
  8. 8Institute of Neuropathology, University Medical Centre Hamburg, Germany
  9. 9SC Neurologia 1 – Ospedale Maria Vittoria, Torino, Italy
  10. 10Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy


Introduction Sporadic CJD (sCJD) is universally fatal. While median survival is 5 months, there is consider- able heterogeneity with some surviving weeks while others survive several months or years. We sought to evaluate characteristics influencing disease duration, and the performance of latest diagnostic criteria incorporating cortical ribboning on MRI brain and the RT-QuIC assay.

Methods 501 autopsy-confirmed cases from surveillance centres in the UK, France, Germany and Italy were stratified into short (<75 days), typical (75-222 days) and long (>222 days) survival groups. We evaluated clinical features, investigation results, and diagnostic criteria classification.

Results Short survival was associated with male sex (p=0.02) and older age (p=0.004). Prion protein gene codon 129 polymorphism status greatly influenced duration (p=<0.001, with longest survival in methionine- valine heterozygotes). Extrapyramidal features were most frequent in long survivors (p=0.04). EEG and 14-3-3 were most sensitive with short survival (p<0.001), RT-QuIC with typical survival (p=0.03) and MRI sen- sitivity did not vary (p=0.4). Previous diagnostic criteria lacked sensitivity in long survivors (p=0.001) while updated criteria were equivalent between groups (p=0.19): sensitivity for long survivors increased 27.7%.

Conclusions This study demonstrates important factors influencing survival and associated phenotypes. The latest diagnostic criteria for sCJD have significantly enhanced diagnosis in long survivors.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.